Chemical typing of amyloid protein contained in formalin-fixed paraffin-embedded biopsy specimens

American Journal of Clinical Pathology

Volumn 116, Issue 1, 2001, Pages 135-142

  Murphy, Charles L ^a   Eulitz, Manfred ^a,b   Hrncic, Rudi ^a   Sletten, Knut ^a,c   Westermark, Per ^a,d   Williams, Teresa ^a   Macy, Sallie D ^a   Wooliver, Craig ^a   Wall, Jonathan ^a   Weiss, Deborah T ^a   Solomon, Alan ^a,e  

^a UNIVERSITY OF TENNESSEE GRADUATE SCHOOL OF MEDICINE   (United States)

^b INSTITUTE OF EPIDEMIOLOGY   (Germany)

^c UNIVERSITY OF OSLO   (Norway)

^d UPPSALA UNIVERSITY   (Sweden)

^e UNIVERSITY OF TENNESSEE MEDICAL CENTER   (United States)

Author keywords

Amyloid; Amyloid typing; Amyloidosis; Chemical characterization; Formalin fixation

Indexed keywords

AMYLOID PROTEIN; FORMALDEHYDE; PARAFFIN;

AMINO ACID SEQUENCE; AMYLOIDOSIS; ARTICLE; BIOPSY; CHEMICAL COMPOSITION; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MASS SPECTROMETRY; PRIORITY JOURNAL; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;

AMINO ACID SEQUENCE; AMYLOID; AMYLOIDOSIS; BIOPSY; FIXATIVES; FORMALDEHYDE; HUMANS; IMMUNOHISTOCHEMISTRY; MOLECULAR SEQUENCE DATA; PARAFFIN EMBEDDING; SPLEEN; TISSUE EXTRACTS;

EID: 17844409327     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1309/TWBM-8L4E-VK22-FRH5     Document Type: Article

References (41)

1. Gillmore JD, Hawkins PN, Pepys MB. Amyloidosis: a review of recent diagnostic and therapeutic developments. Br J Haematol. 1997;99:245-256.
2. Westermark P, Araki S, Benson MD, et al. Nomenclature of amyloid fibril proteins: report from the meeting of the International Nomenclature Committee on Amyloidosis, August 8-9, 1998, part 1. Amyloid. 1999;6:63-66.
3. Kyle RA, Gertz MA. Primary systemic amyloidosis: clinical and laboratory features in 474 cases. Semin Hematol. 1995; 32:45-59.
4. Falk RH, Comenzo RL, Skinner M. The systemic amyloidoses. N Engl J Med. 1997;337:898-909.
5. Wright JR, Calkins E, Humphrey RL. Potassium permanganate reaction in amyloidosis: a histologic method to assist in differentiating forms of this disease. Lab Invest. 1977;36:274-281.
6. Westermark GT, Johnson KH, Westermark P. Staining methods for identification of amyloid in tissue. Methods Enzymol. 1999;309:3-25.
7. Linke RP. Immunochemical typing of amyloid deposits after microextraction from biopsies. Appl Pathol. 1985;3:18-28.
8. van de Kaa CA, Hol PR, Huber J, et al. Diagnosis of the type of amyloid in paraffin wax embedded tissue sections using antisera against human and animal amyloid proteins. Virchows Arch A Pathol Anat Histopathol. 1986;408:649-664.
9. Picken MM, Pelton K, Frangione B, et al. Primary amyloidosis A: immunohistochemical and biochemical characterization. Am J Pathol. 1987;129:536-542.
10. Röcken C, Schwotzer EB, Linke RP, et al. The classification of amyloid deposits in clinicopathological practice. Histopathology. 1996;29:325-335.
11. Kaplan B, Yakar S, Kumar A, et al. Immunochemical characterization of amyloid in diagnostic biopsy tissue. Amyloid. 1997;4:80-86.
12. Kaplan B, Vidal R, Kumar A, et al. Immunochemical microanalysis of amyloid proteins in fine-needle aspirates of abdominal fat. Am J Clin Pathol. 1999;112:403-407.
13. Olsen KE, Sletten K, Westermark P. The use of subcutaneous fat tissue for amyloid typing by enzyme linked immunosorbent assay. Am J Clin Pathol. 1999;111:355-362.
14. Solomon A, Weiss DT. Protein and host factors implicated in the pathogenesis of light chain amyloidosis (AL amyloidosis). Amyloid. 1995;2:269-279.
15. Westermark P, Benson L, Juul J, et al. Use of subcutaneous abdominal fat biopsy specimen for detailed typing of amyloid fibril protein-AL by amino acid sequence analysis. J Clin Pathol. 1989;42:817-819.
16. Castaño EM, Prelli F, Morelli L, et al. Immunoglobulin lambda light chains are the precursors of ureteral localized amyloidosis: a micromethod for extraction of amyloid. Amyloid. 1997;4:253-258.
17. Olsen KE, Sletten K, Westermark P. Extended analysis of AL-amyloid protein from abdominal wall subcutaneous fat biopsy: kappa IV immunoglobulin light chain. Biochem Biophys Res Commun. 1998;245:713-716.
18. Kaplan B, Hrncic R, Murphy CL, et al. Microextraction and purification techniques applicable to chemical characterization of amyloid proteins in minute amounts of tissue. Methods Enzymol. 1999;309:67-81.
19. Kaplan B, Murphy CL, Ratner V, et al. Micro-method to isolate and purify amyloid proteins for chemical characterization. Amyloid. 2001;8:22-29.
20. Shtrasburg S, Pras M, Langevitch P, et al. Demonstration of AA-protein in formalin-fixed, paraffin-embedded tissues. Am J Pathol. 1982;106:141-144.
21. Linke RP, Heilmann KL, Nathrath WBJ, et al. Identification of amyloid A protein in a sporadic Muckle-Wells syndrome: N-terminal amino acid sequence after isolation from formalin-fixed tissue. Lab Invest. 1983;48:698-704.
22. Layfield R, Bailey K, Lowe J, et al. Extraction and protein sequencing of immunoglobulin light chain from formalin-fixed cerebrovascular amyloid deposits. J Pathol. 1996;180:455-459.
23. Layfield R, Bailey K, Dineen R, et al. Application of formalin fixation to the purification of amyloid proteins. Anal Biochem. 1997;253:142-144.
24. Ikeda K, Monden T, Kanoh T, et al. Extraction and analysis of diagnostically useful proteins from formalin-fixed, paraffin-embedded tissue sections. J Histochem Cytochem. 1998;46:397-403.
25. Solomon A, Weiss DT, Macy SD, et al. Immunocytochemical detection of kappa and lambda light chain V region subgroups in human B-cell malignancies. Am J Pathol. 1990;137:855-862.
26. Kabat EA, Wu TT, Perry HM, et al. Sequences of Proteins of Immunologic Interest. 5th ed. Bethesda, MD: US Dept. Health and Human Services; 1991.
27. Wallace MR, Dwulet FE, Conneally PM, et al. Biochemical and molecular genetic characterization of a new variant prealbumin associated with hereditary amyloidosis. J Clin Invest. 1986;78:6-12.
28. Sidoni A, Alberti PF, Bravi S, et al. Amyloid tumors in the soft tissues of the legs: case report and review of the literature. Virchows Arch. 1998;432:563-566.
29. Walker JF. Reactions of formaldehyde with amines, amides and nitrites. In: Formaldehyde. 3rd ed. New York, NY: Reinhold Publishing; 1964:359-414.
30. Westermark P, Nilsson GT. Demonstration of amyloid protein AA in old museum specimens. Arch Pathol Lab Med. 1984;108:217-219.
31. Kyle, RA. Amyloidosis, part 3: secondary amyloidosis. Int J Dermatol. 1981;20:75-80.
32. Comenzo RL, Vosburgh E, Falk RH, et al. Dose-intensive melphalan with blood stem-cell support for the treatment of AL (amyloid light-chain) amyloidosis: survival and responses in 25 patients. Blood. 1998;91:3662-3670.
33. Benson MD, Clemicki T. Transthyretin amyloidosis. Amyloid. 1996;3:44-56.
34. Soto C, Kindy MS, Baumann M, et al. Inhibition of Alzheimer's amyloidosis by peptides that prevent beta-sheet conformation. Biochem Biophys Res Commun. 1996;226:672-680.
35. Gianni L, Bellotti V, Gianni AM, et al. New drug therapy of amyloidoses: resorption of AL-type deposits with 4′-iodo-4′-deoxydoxorubicin. Blood. 1995;86:855-861.
36. Tennent GA, Lovat LB, Pepys MB. Serum amyloid P component prevents proteolysis of the amyloid fibrils of Alzheimer disease and systemic amyloidosis. Proc Natl Acad Sci U S A. 1995;92:4299-4303.
37. Kisilevsky R, Lemieux LJ, Fraser PE, et al. Arresting amyloidosis in vivo using small-molecule anionic sulphonates or sulphates: implication for Alzheimer's disease. Nat Med. 1995;1:143-148.
38. Ancsin JB, Kisilevsky R. The heparin/heparan sulfate-binding site on apo-serum amyloid A: implications for the therapeutic intervention of amyloidosis. J Biol Chem. 1999;274:7172-7181.
39. Schenk D, Barbour R, Dunn W, et al. Immunization with amyloid-beta attenuates Alzheimer disease-like pathology in the PDAPP mouse. Nature. 1999;400:173-177.
40. Hrncic R, Wall J, Wolfenbarger DA, et al. Antibody-mediated resolution of light chain-associated amyloid deposits. Am J Pathol. 2000;157:1239-1246.
41. Bard F, Cannon C, Barbour R, et al. Peripherally administered antibodies against amyloid beta-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease. Nat Med. 2000;6:916-919.